Biodegradable tracheal stents: our ten-year experience with adult patients

. 2024 May 15 ; 24 (1) : 238. [epub] 20240515

Jazyk angličtina Země Velká Británie, Anglie Médium electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid38750487
Odkazy

PubMed 38750487
PubMed Central PMC11094873
DOI 10.1186/s12890-024-03057-y
PII: 10.1186/s12890-024-03057-y
Knihovny.cz E-zdroje

BACKGROUND: Biodegradable (BD) stents made from polydioxanone have been used only in human airways. These stents combine the advantages of classical tracheal stents, and fewer side effects are expected due to their biocompatibility and their time-limited presence in airways. However, new clinical consequences have arisen. Here, the authors share their experiences with BD stents for tracheal indications, focusing on their safety and efficacy. METHODS: This was a retrospective review of a collected database of adult patients who underwent implantation of biodegradable tracheal stents between September 2013 and December 2022 at the Department of Respiratory Medicine of the 1st Faculty of Medicine in Prague and Thomayer University Hospital. The indications included functionally significant nonmalignant tracheal stenosis and tracheomalacia. Self-expandable, biodegradable, polydioxanone tracheal stents manufactured by ELLA-CS Ltd. (Hradec Kralove, Czech Republic) were implanted during rigid bronchoscopy under general anaesthesia. All patients were followed up in the department and were provided with the necessary care. The main efficacy and safety parameters and relationships were analysed using descriptive statistics and Fisher´s exact, Wilcoxon and Kruskal‒Wallis tests. RESULTS: A total of 65 stents were implanted in 47 adult patients. During the first two months after implantation, when adequate function was expected, the stent was found to be effective in 26 out of 39 patients who completed this period (66.7%). The clinical effectiveness reached 89.7%, as early restenoses were mostly mild and necessitated treatment in only 4 patients. The frequencies of significant mucostasis, migration and granulation tissue growth were 2.6%, 7.5% and 23.1%, respectively, during this period. Thirty-four participants completed the half-year follow-up period after the first or second stent insertion, and some were followed up beyond this period. Poor control of symptoms, the development of restenosis and the need for interventions were characteristic of this period as the stents degraded. Twenty-two patients who experienced remodelling or stabilization of the tracheal lumen achieved a stent-free state. Seven patients underwent subsequent surgical treatment. CONCLUSIONS: BD stents are safe and provide adequate tracheal support until they begin to degrade. The use of BD stents necessitates close monitoring of patients and accurate treatment of possible restenosis. TRIAL REGISTRATION: Based on project NT14146 - Biodegradable stents in the management of the large airways (2013-2015, MZ0/NT), registered on May 1, 2013, in the Research and Development and Innovation Information System of the Czech Republic and at ClinicalTrials.gov (reg. no. NCT02620319, December 2, 2015).

Zobrazit více v PubMed

Mathew R, Hibare K, Dalar L, Roy WE. Tracheobronchial stent sizing and deployment practices airway stenting practices around the world: a survey study. J Thorac Dis. 2020;12:5495–5504. doi: 10.21037/jtd-20-2080. PubMed DOI PMC

Novotny L, Crha M, Rauser P, Hep A, Misik J, Necas A, et al. Novel biodegradable polydioxanone stent in a rabbit airway model. J Thorac Cardiovasc Surg. 2012;143:437–444. doi: 10.1016/j.jtcvs.2011.08.002. PubMed DOI

Lischke R, Pozniak J, Vondrys D, Elliott MJ. Novel biodegradable stents in the treatment of bronchial stenosis after lung transplantation. Eur J Cardiothorac Surg. 2011;40:619–624. PubMed

Vondrys D, Elliott MJ, McLaren CA, Noctor C, Roebuck DJ. First experience with biodegradable airway stents in children. Ann Thorac Surg. 2011;92(5):1870–1874. doi: 10.1016/j.athoracsur.2011.07.042. PubMed DOI

Antón-Pacheco JL, Luna C, García E, López M, Morante R, Tordable C, Palacios A, de Miguel M, Benavent I, Gómez A. Initial experience with a new biodegradable airway stent in children: is this the stent we were waiting for? Pediatr Pulmonol. 2016;51(6):607–612. doi: 10.1002/ppul.23340. PubMed DOI

Stehlik L, Hytych V, Letackova J, Kubena P, Vasakova M. Biodegradable polydioxanone stents in the treatment of adult patients with tracheal narrowing. BMC Pulm Med. 2015;21(15):164. doi: 10.1186/s12890-015-0160-6.. PubMed DOI PMC

Freitag L, Ernst A, Unger M, Kovitz K, Marquette CH. A proposed classification system of central airway stenosis. Eur Respir J. 2007;30(1):7–12. doi: 10.1183/09031936.00132804. PubMed DOI

Hytych V, Horazdovsky P, Stehlik L, Pracharova S, Pohnan R, Lefnerova S, Vasakova M. Our own method of fixation of biodegradable tracheal stent. Bratisl Lek Listy. 2015;116(5):340–342. doi: 10.4149/bll_2015_064. PubMed DOI

Guibert N, Saka H, Dutau H. Airway stenting: technological advancements and its role in interventional pulmonology. Respirology. 2020;25(9):953–962. doi: 10.1111/resp.13801. PubMed DOI

Zou H, Zhang J, Zhan K, Mou XZ, Zhu B. A narrative review of new research progress regarding the use of airway stents in benign airway stenosis. Expert Rev Respir Med. 2022;16(6):651–659. doi: 10.1080/17476348.2022.2099379. PubMed DOI

Freitag L. Airway stents in Interventional Pulmonology. Eur Respir Soc Monogr. 2010;48:190.

Mehta RM, Singla A, Shah A, Loknath C. The, "Hitch Stitch": an effective method of preventing migration in high Tracheal Stenosis. Respiration. 2017;93(2):106–111. doi: 10.1159/000453075. PubMed DOI

Shin B, Kim K, Jeong BH, Eom JS, Song WJ, Kim H. Clinical implications of differentiating between types of post-tracheostomy tracheal stenosis. J Thorac Dis. 2017;9(11):4413–4423. doi: 10.21037/jtd.2017.10.99. PubMed DOI PMC

Karush JM, Seder CW, Raman A, et al. Durability of silicone airway stents in the management of benign central airway obstruction. Lung. 2017;195:601–606. doi: 10.1007/s00408-017-0023-4. PubMed DOI

Dahlqvist C, Ocak S, Gourdin M, Dincq AS, Putz L, d'Odémont JP. Fully covered metallic stents for the treatment of benign airway stenosis. Can Respir J. 2016;2016:8085216. doi: 10.1155/2016/8085216. PubMed DOI PMC

Fortin M, Lacasse Y, Elharrar X, Tazi-Mezalek R, Laroumagne S, Guinde J, Astoul P, Dutau H. Safety and efficacy of a fully covered self-expandable metallic stent in benign airway stenosis. Respiration. 2017;93(6):430–435. doi: 10.1159/000472155. PubMed DOI

Dumon JF, Cavaliere S, Diaz-Jimenez JP, Vergnon JM, Venuta F, Dumon MC, Kovitz K. Seven-year experience with the dumon prosthesis. J Bronchol. 1996;3(1):6–10. doi: 10.1097/00128594-199601000-00003. DOI

Vergnon JM, Costes F, Polio JC. Efficacy and tolerance of a new silicone stent for the treatment of benign tracheal stenosis: preliminary results. Chest. 2000;118(2):422–426. doi: 10.1378/chest.118.2.422. PubMed DOI

Sztanó B, Kiss G, Márai K, Rácz G, Szegesdi I, Rácz K, Katona G, Rovó L. Biodegradable airway stents in infants - Potential life-threatening pitfalls. Int J Pediatr Otorhinolaryngol. 2016;91:86–89. doi: 10.1016/j.ijporl.2016.10.013. PubMed DOI

Brichet A, Verkindre C, Dupont J, Carlier ML, Darras J, Wurtz A, Ramon P, Marquette CH. Multidisciplinary approach to management of postintubation tracheal stenoses. Eur Respir J. 1999;13(4):888–893. doi: 10.1034/j.1399-3003.1999.13d32.x. PubMed DOI

Xiong XF, Xu L, Fan LL, Cheng DY, Zheng BX. Long-term follow-up of self-expandable metallic stents in benign tracheobronchial stenosis: a retrospective study. BMC Pulm Med. 2019;19(1):33. doi: 10.1186/s12890-019-0793-y. PubMed DOI PMC

Morante-Valverde R, Usategui A, López M, Grau M, Luna-Paredes MC, Albi S, Alonso-Riaño M, Pablos JL, Antón-Pacheco JL. Histological and structural effects of biodegradable polydioxanone stents in the rabbit trachea. Eur J Cardiothorac Surg. 2022;62(2):ezac380. doi: 10.1093/ejcts/ezac380. PubMed DOI

Choi JS, Seok J, Eom MR, Jung E, Park SA, Joo SM, Jun YJ, Son KW, Kwon SK. Endoscopically applied biodegradable stent in a rabbit model of pediatric Tracheomalacia. Clin Exp Otorhinolaryngol. 2021;14(3):328–337. doi: 10.21053/ceo.2020.01627. PubMed DOI PMC

Rodriguez-Zapater S, Serrano-Casorran C, Guirola JA, Lopez-Minguez S, Bonastre C, de Gregorio MA. Reactivity study of a biodegradable polydioxanone tracheal stent in a rabbit model. Arch Bronconeumol (Engl Ed) 2020;56(10):643–650. doi: 10.1016/j.arbres.2020.02.008. PubMed DOI

Noppen M, Stratakos G, Amjadi K, De Weerdt S, D’Haese J, Meysman M, et al. Stenting allows weaning and extubation in ventilator- or tracheostomy dependency secondary to benign airway disease. Respir Med. 2007;101:139–145. doi: 10.1016/j.rmed.2006.03.037. PubMed DOI

Di Dedda G, Mirabile C. Use of a biodegradable, oversized stent in a child with tracheomalacia secondary to vascular external compression. Cardiol Young. 2017;27(1):196–198. doi: 10.1017/S104795111600113X. PubMed DOI

Sun K, Zhang H, Zhang W, Cheng Y, Wang G. Long-term prognostic factors of clinical success after interventional bronchoscopy in patients with scarring central airway stenosis. BMC Pulm Med. 2021;21(1):73. doi: 10.1186/s12890-021-01434-5. PubMed DOI PMC

Dutau H, Maldonado F, Laroumagne S, et al. Silicone stents, the rigid bronchoscope, and the standard of care in central airway stenosis. Curr Respir Care Rep. 2012;1:46–53. doi: 10.1007/s13665-011-0003-8. DOI

Galluccio G, Lucantoni G, Battistoni P, Paone G, Batzella S, Lucifora V, Dello Iacono R. Interventional endoscopy in the management of benign tracheal stenoses: definitive treatment at long-term follow-up. Eur J Cardiothorac Surg. 2009;35(3):429–33. doi: 10.1016/j.ejcts.2008.10.041. PubMed DOI

Zobrazit více v PubMed

ClinicalTrials.gov
NCT02620319

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...